These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 17602742

  • 1. Substance P receptor expression in patients with inflammatory bowel disease. Determination by three different techniques, i.e., storage phosphor autoradiography, RT-PCR and immunohistochemistry.
    ter Beek WP, Biemond I, Muller ES, van den Berg M, Lamers CB.
    Neuropeptides; 2007 Oct; 41(5):301-6. PubMed ID: 17602742
    [Abstract] [Full Text] [Related]

  • 2. Increase in substance P precursor mRNA in noninflamed small-bowel sections in patients with Crohn's disease.
    Michalski CW, Autschbach F, Selvaggi F, Shi X, Di Mola FF, Roggo A, Müller MW, Di Sebastiano P, Büchler MW, Giese T, Friess H.
    Am J Surg; 2007 Apr; 193(4):476-81. PubMed ID: 17368292
    [Abstract] [Full Text] [Related]

  • 3. Gastrin releasing peptide receptor expression is decreased in patients with Crohn's disease but not in ulcerative colitis.
    ter Beek WP, Muller ES, Van Hogezand RA, Biemond I, Lamers CB.
    J Clin Pathol; 2004 Oct; 57(10):1047-51. PubMed ID: 15452158
    [Abstract] [Full Text] [Related]

  • 4. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
    Vuckovic S, Florin TH, Khalil D, Zhang MF, Patel K, Hamilton I, Hart DN.
    Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
    [Abstract] [Full Text] [Related]

  • 5. Motilin receptor expression in smooth muscle, myenteric plexus, and mucosa of human inflamed and noninflamed intestine.
    Ter Beek WP, Muller ES, van den Berg M, Meijer MJ, Biemond I, Lamers CB.
    Inflamm Bowel Dis; 2008 May; 14(5):612-9. PubMed ID: 18183601
    [Abstract] [Full Text] [Related]

  • 6. From model cell line to in vivo gene expression: disease-related intestinal gene expression in IBD.
    Schulze HA, Häsler R, Mah N, Lu T, Nikolaus S, Costello CM, Schreiber S.
    Genes Immun; 2008 Apr; 9(3):240-8. PubMed ID: 18340362
    [Abstract] [Full Text] [Related]

  • 7. Decreased Toll-like receptor-5 (TLR-5) expression in the mucosa of ulcerative colitis patients.
    Stanislawowski M, Wierzbicki PM, Golab A, Adrych K, Kartanowicz D, Wypych J, Godlewski J, Smoczynski M, Kmiec Z.
    J Physiol Pharmacol; 2009 Oct; 60 Suppl 4():71-5. PubMed ID: 20083854
    [Abstract] [Full Text] [Related]

  • 8. Expression of macrophage-colony stimulating factor in normal and inflammatory bowel disease intestine.
    Klebl FH, Olsen JE, Jain S, Doe WF.
    J Pathol; 2001 Dec; 195(5):609-15. PubMed ID: 11745698
    [Abstract] [Full Text] [Related]

  • 9. Differential mucosal expression of three superoxide dismutase isoforms in inflammatory bowel disease.
    Kruidenier L, Kuiper I, van Duijn W, Marklund SL, van Hogezand RA, Lamers CB, Verspaget HW.
    J Pathol; 2003 Sep; 201(1):7-16. PubMed ID: 12950012
    [Abstract] [Full Text] [Related]

  • 10. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.
    Kruidenier L, Kuiper I, Lamers CB, Verspaget HW.
    J Pathol; 2003 Sep; 201(1):28-36. PubMed ID: 12950014
    [Abstract] [Full Text] [Related]

  • 11. Overexpression of leptin mRNA in mesenteric adipose tissue in inflammatory bowel diseases.
    Barbier M, Vidal H, Desreumaux P, Dubuquoy L, Bourreille A, Colombel JF, Cherbut C, Galmiche JP.
    Gastroenterol Clin Biol; 2003 Nov; 27(11):987-91. PubMed ID: 14732844
    [Abstract] [Full Text] [Related]

  • 12. Suppression of Na+/H+ exchanger isoform-3 in human inflammatory bowel disease: lack of reversal by 5'-aminosalicylate treatment.
    Siddique I, Hasan F, Khan I.
    Scand J Gastroenterol; 2009 Nov; 44(1):56-64. PubMed ID: 18785066
    [Abstract] [Full Text] [Related]

  • 13. Bone marrow transplantation ameliorates pathology in interleukin-10 knockout colitic mice.
    Bamba S, Lee CY, Brittan M, Preston SL, Direkze NC, Poulsom R, Alison MR, Wright NA, Otto WR.
    J Pathol; 2006 Jun; 209(2):265-73. PubMed ID: 16550633
    [Abstract] [Full Text] [Related]

  • 14. Changes in mRNA expression levels of solute carrier transporters in inflammatory bowel disease patients.
    Wojtal KA, Eloranta JJ, Hruz P, Gutmann H, Drewe J, Staumann A, Beglinger C, Fried M, Kullak-Ublick GA, Vavricka SR.
    Drug Metab Dispos; 2009 Sep; 37(9):1871-7. PubMed ID: 19487253
    [Abstract] [Full Text] [Related]

  • 15. Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease.
    Banks C, Bateman A, Payne R, Johnson P, Sheron N.
    J Pathol; 2003 Jan; 199(1):28-35. PubMed ID: 12474223
    [Abstract] [Full Text] [Related]

  • 16. Improvement of real-time polymerase chain reaction for quantifying TNF-alpha mRNA expression in inflamed colorectal mucosa: an approach to optimize procedures for clinical use.
    Cui G, Olsen T, Christiansen I, Vonen B, Florholmen J, Goll R.
    Scand J Clin Lab Invest; 2006 Jan; 66(3):249-59. PubMed ID: 16714253
    [Abstract] [Full Text] [Related]

  • 17. Increased lymphatic vessel density and lymphangiogenesis in inflammatory bowel disease.
    Rahier JF, De Beauce S, Dubuquoy L, Erdual E, Colombel JF, Jouret-Mourin A, Geboes K, Desreumaux P.
    Aliment Pharmacol Ther; 2011 Sep; 34(5):533-43. PubMed ID: 21736598
    [Abstract] [Full Text] [Related]

  • 18. Immunolocalization and expression of kinin B1R and B2R receptors in human inflammatory bowel disease.
    Stadnicki A, Pastucha E, Nowaczyk G, Mazurek U, Plewka D, Machnik G, Wilczok T, Colman RW.
    Am J Physiol Gastrointest Liver Physiol; 2005 Aug; 289(2):G361-6. PubMed ID: 15805101
    [Abstract] [Full Text] [Related]

  • 19. Intestinal tissue kallikrein-kallistatin profile in inflammatory bowel disease.
    Stadnicki A, Mazurek U, Plewka D, Wilczok T.
    Int Immunopharmacol; 2003 Jul; 3(7):939-44. PubMed ID: 12810351
    [Abstract] [Full Text] [Related]

  • 20. Imbalanced secondary mucosal antioxidant response in inflammatory bowel disease.
    Kruidenier L, Kuiper I, Van Duijn W, Mieremet-Ooms MA, van Hogezand RA, Lamers CB, Verspaget HW.
    J Pathol; 2003 Sep; 201(1):17-27. PubMed ID: 12950013
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.